We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-4.39%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$5.5B
(-7.4%)
Cap. Flow
-$9.75B
Cap. Flow
% of AUM
-14.25%
Top 10 Holdings %
Top 10 Hldgs %
21.66%
Holding
2,644
New
225
Increased
638
Reduced
796
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$284M |
| 2 |
Icon
ICLR
|
+$148M |
| 3 |
Estee Lauder
EL
|
+$128M |
| 4 |
eBay
EBAY
|
+$127M |
| 5 |
Envista
NVST
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$375M |
| 2 |
NorthWestern Energy
NWE
|
+$293M |
| 3 |
Consolidated Edison
ED
|
+$202M |
| 4 |
Medtronic
MDT
|
+$201M |
| 5 |
Ameren
AEE
|
+$156M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.01% |
| 2 | Healthcare | 14.76% |
| 3 | Financials | 13.61% |
| 4 | Industrials | 11.37% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Equinor
EQNR
$94.8B
| $32.5M | 0.05% |
981,595
-494,046
| -33% | -$17.8M |
|
202
AbCellera Biologics
ABCL
$1.78B
| $32.5M | 0.05% |
3,285,022
-61,475
| -2% | -$674K |
|
203
Ingevity
NGVT
$2.52B
| $32.2M | 0.05% |
531,525
-64,513
| -11% | -$4.33M |
|
204
Leslie's
LESL
$10.1M
| $32.2M | 0.05% |
109,446
-285
| -0.3% | -$85.6K |
|
205
Ulta Beauty
ULTA
$23B
| $32.2M | 0.05% |
80,156
+7,502
| +10% | +$3.02M |
|
206
Gilead Sciences
GILD
$163B
| $32M | 0.05% |
519,465
+121,154
| +30% | +$7.64M |
|
207
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $31.2M | 0.05% |
711,425
-34,800
| -5% | -$1.68M |
|
208
Exelon
EXC
$47B
| $31.1M | 0.05% |
831,285
-94,602
| -10% | -$4.18M |
|
|
SPLK
209
DELISTED
Splunk Inc
SPLK
| $31.1M | 0.05% |
413,712
-26
| -0% | -$2.55K |
|
210
Chubb
CB
$134B
| $31.1M | 0.05% |
170,745
+23,886
| +16% | +$4.54M |
|
211
Ecolab
ECL
$78.6B
| $30.8M | 0.04% |
212,955
-909
| -0.4% | -$147K |
|
212
Cencora
COR
$60B
| $30.5M | 0.04% |
225,048
+1,855
| +0.8% | +$266K |
|
213
Curtiss-Wright
CW
$27.6B
| $30.4M | 0.04% |
218,405
-137,545
| -39% | -$19.5M |
|
214
Trip.com Group
TCOM
$29.8B
| $30.3M | 0.04% |
1,109,201
+220,218
| +25% | +$5.77M |
|
215
CF Industries
CF
$18.2B
| $30.3M | 0.04% |
314,680
+51,467
| +20% | +$5.02M |
|
216
Molina Healthcare
MOH
$10.2B
| $30.3M | 0.04% |
91,731
+51,184
| +126% | +$16.5M |
|
217
Sociedad Química y Minera de Chile
SQM
$19.1B
| $30.1M | 0.04% |
332,028
+152,083
| +85% | +$14.8M |
|
218
iShares Core S&P Small-Cap ETF
IJR
$111B
| $30M | 0.04% |
344,193
-23,381
| -6% | -$2.27M |
|
219
Coca-Cola Femsa
KOF
$22.5B
| $29.9M | 0.04% |
512,587
+103,966
| +25% | +$6.2M |
|
220
Antero Resources
AR
$11.2B
| $29.4M | 0.04% |
964,485
-170,212
| -15% | -$6.28M |
|
221
Nasdaq
NDAQ
$52.6B
| $29.3M | 0.04% |
516,890
+516,830
| +861,383% | +$30.4M |
|
|
TWN
222
Taiwan Fund
TWN
$482M
| $29.2M | 0.04% |
1,388,098
-33,134
| -2% | -$813K |
|
223
Automatic Data Processing
ADP
$107B
| $28.6M | 0.04% |
126,652
+7,749
| +7% | +$1.83M |
|
224
SBA Communications
SBAC
$19B
| $28.6M | 0.04% |
100,486
-101
| -0.1% | -$32.8K |
|
225
Campbell Soup
CPB
$6.67B
| $28.5M | 0.04% |
605,633
+280,235
| +86% | +$13.7M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Lazard Asset Management held 2,644 positions worth $68.4B, down 7.4% from $73.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $9.75B in Q3 2022, closing 294 positions and reducing 796 holdings. Its most notable exit was Nielsen Holdings plc, an estimated $99M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Cardinal Health worth $11.3M.
- Lazard Asset Management's largest Q3 2022 buy was Cardinal Health: 169,616 shares worth $11.3M.
- Lazard Asset Management added most to Norfolk Southern in Q3 2022, an estimated $284M increase.
- Lazard Asset Management's biggest Q3 2022 reduction was Lowe's Companies, cutting an estimated $375M.
- Lazard Asset Management fully exited Nielsen Holdings plc in Q3 2022, selling an estimated $99M.
- Lazard Asset Management's ten largest holdings make up 22% of its $68.4B portfolio in Q3 2022.
- Lazard Asset Management opened 225 new positions and closed 294 in Q3 2022.
- Lazard Asset Management's portfolio value fell 7.4% quarter-over-quarter to $68.4B.
Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.